FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

RXQ Compounding Recalls Sterile Drug Products

RXQ Compounding recalls all sterile human and animal products within expiry due to a lack of sterility process assurance associated with sterile produ...

Medical Devices

Imarc Details BIMO Findings

Imarc lists seven causes of non-compliant studies found in FY 2017 FDA Bioresearch Monitoring inspections.

Medical Devices

GE Healthcare Recalls Infant Warmers

GE Healthcare recalls all Giraffe Warmers and Panda iRes Infant Warmers because bedside panels and latch areas on beds may crack, break or become dama...

Federal Register

Comments Extended for Cannabis Product Info

Federal Register notice: FDA extends the comment period until 7/16 that seeks input and scientific data about the safety, manufacturing, product quali...

Federal Register

Info Collection on OTC Drug Labeling Format

Federal Register notice: FDA seeks comments on an information collection extension entitled Format and Content Requirements for Over-the-Counter Drug ...

Human Drugs

FDA Downgrades Foreign Inspections: Book

Bottle of Lies author Katherine Eban says she finds it disturbing that FDA supervisors are downgrading the severity of foreign inspection findings and...

Human Drugs

Companies on Bispecific Antibody Development

Five drug companies comment on an FDA draft guidance on bispecific antibody development.

Human Drugs

FDA Will Allow Some Omega-3 Health Claims

FDA says it will use enforcement discretion to not act against certain food or dietary supplement health claims for omega-3 fatty acids.

Human Drugs

Multiple Dietary Supplement Violations at PRL

FDA warns PRL, Inc., about CGMP and other violations in its production of dietary supplements.

Human Drugs

FDA Enhances Paragraph 4 Patent List

FDA acting commissioner Ned Sharpless says the agency is enhancing the data in the generic drug Paragraph 4 patent certification list as part of an ef...